Home
IMNN
IMNN News

Latest Imunon Inc. (IMNN) News on December 18, 2024

IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001

GlobeNewswire

8 days ago

IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001

Zacks Small Cap Research

23 days ago

IMNN: Comes to Alignment with FDA Regarding Phase 3 Protocol for IMNN-001…

IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer

GlobeNewswire

23 days ago

IMUNON Announces Results from its End-of-Phase 2 Meeting with the FDA for its Lead IMNN-001 Clinical Program in Advanced Ovarian Cancer

Zacks Small Cap Research

a month ago

IMNN: Meeting with FDA in Preparation for Phase 3 Ovarian Cancer Trial

Imunon Inc (IMNN) Q3 2024 Earnings Call Highlights: Promising Clinical Advances Amid Financial ...

GuruFocus.com

a month ago

Imunon Inc (IMNN) Q3 2024 Earnings Call Highlights: Promising Clinical Advances Amid Financial ...

IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting

GlobeNewswire

a month ago

IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting

IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

a month ago

IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates

IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024

GlobeNewswire

2 months ago

IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024

IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting

GlobeNewswire

2 months ago

IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting

Imunon reports inducement grant under NASDAQ listing rule

TipRanks

2 months ago

Imunon reports inducement grant under NASDAQ listing rule

IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

GlobeNewswire

3 months ago

UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

GlobeNewswire

3 months ago

IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

MT Newswires

4 months ago

Imunon Files for Stock Resale by Security Holders

IMUNON to Host R&D Day on September 18th

GlobeNewswire

4 months ago

IMUNON to Host R&D Day on September 18th

IMNN: Positive Results for OVATION 2 Trial Supports Advancing IMNN-001 Into Phase 3 Study…

Zacks Small Cap Research

4 months ago

IMNN: Positive Results for OVATION 2 Trial Supports Advancing IMNN-001 Into Phase 3 Study…

IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

4 months ago

IMUNON Reports Second Quarter 2024 Financial Results and Provides a Business Update

IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024

GlobeNewswire

4 months ago

IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024

MT Newswires

5 months ago

Top Midday Decliners

Imunon’s shares soar after IL-12 therapy success in Phase II trial

Pharmaceutical Technology

5 months ago

Imunon’s shares soar after IL-12 therapy success in Phase II trial

IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

GlobeNewswire

5 months ago

IMUNON Announces $10 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

MT Newswires

5 months ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires

5 months ago

Sector Update: Health Care

MT Newswires

5 months ago

Top Midday Gainers

MT Newswires

5 months ago

Imunon Says Phase 2 Trial Data of Ovarian Cancer Treatment Showed Increase in Overall Survival; Shares Jump

IMUNON Announces 11.1 Month Increase in Overall Survival in Patients with Newly Diagnosed, Advanced Ovarian Cancer Treated with IMNN-001

GlobeNewswire

5 months ago

IMUNON Announces 11.1 Month Increase in Overall Survival in Patients with Newly Diagnosed, Advanced Ovarian Cancer Treated with IMNN-001

IMUNON to Report Topline Results from the Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer Tomorrow

GlobeNewswire

5 months ago

IMUNON to Report Topline Results from the Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer Tomorrow

IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer

GlobeNewswire

6 months ago

IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

6 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

6 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

6 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

6 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

6 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

6 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

6 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

6 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

6 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Simply Wall St.

6 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Simply Wall St.

6 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Simply Wall St.

6 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

6 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Simply Wall St.

6 months ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Simply Wall St.

6 months ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North

AFP

6 months ago

Seoul resumes loudspeaker propaganda against North

First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial

GlobeNewswire

6 months ago

First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial

Zacks Small Cap Research

7 months ago

IMNN: Results from OVATION 2 Study in Mid-2024…

Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting

GlobeNewswire

7 months ago

Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting

Thomson Reuters StreetEvents

7 months ago

Q1 2024 Imunon Inc Earnings Call

GuruFocus.com

7 months ago

Imunon Inc (IMNN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...

IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study

GlobeNewswire

7 months ago

IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study

IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

7 months ago

IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update

IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

GlobeNewswire

7 months ago

IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024

GlobeNewswire

7 months ago

IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024

IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101

GlobeNewswire

8 months ago

IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101

Zacks Small Cap Research

8 months ago

IMNN: IND Application Submitted for Phase 1/2 Trial of Seasonal COVID-19 Vaccine…

IMUNON Reports Compliance with Nasdaq Listing Requirements

GlobeNewswire

8 months ago

IMUNON Reports Compliance with Nasdaq Listing Requirements

Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript

IMUNON Reports 2023 Financial Results and Provides Business Update

GlobeNewswire

9 months ago

IMUNON Reports 2023 Financial Results and Provides Business Update

IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses

GlobeNewswire

9 months ago

IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses

IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024

GlobeNewswire

9 months ago

IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024

IMUNON Files IND Application to Begin Human Testing of IMNN-101

GlobeNewswire

9 months ago

IMUNON Files IND Application to Begin Human Testing of IMNN-101

IMUNON Announces Leadership Change

GlobeNewswire

9 months ago

IMUNON Announces Leadership Change

Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5

GlobeNewswire

10 months ago

Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5

Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer

GlobeNewswire

10 months ago

Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer

IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine

GlobeNewswire

10 months ago

IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

PR Newswire

a year ago

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

Investors in Genasys (NASDAQ:GNSS) have unfortunately lost 78% over the last three years

Simply Wall St.

a year ago

Investors in Genasys (NASDAQ:GNSS) have unfortunately lost 78% over the last three years

HNR Acquisition Corp Expands Oil Price Hedging Program

ACCESSWIRE

a year ago

HNR Acquisition Corp Expands Oil Price Hedging Program

Signing Day Sports Promotes Holistic Student-Athlete Wellbeing in the Sports Industry

GlobeNewswire

a year ago

Signing Day Sports Promotes Holistic Student-Athlete Wellbeing in the Sports Industry

Pioneer Power Partners with NOMAD Transportable Power Systems to Launch New Zero-Emission, Mobile EV Charging Platform and Re-charging Solutions

Business Wire

a year ago

Pioneer Power Partners with NOMAD Transportable Power Systems to Launch New Zero-Emission, Mobile EV Charging Platform and Re-charging Solutions

Ocean Power Technologies Announces Progress on Shift to Commercialization and Expects to Achieve Profitability in Calendar Year 2025

GlobeNewswire

a year ago

Ocean Power Technologies Announces Progress on Shift to Commercialization and Expects to Achieve Profitability in Calendar Year 2025

Cenntro Electric Group Encourages All Shareholders to Vote in Favor of Proposed Scheme Resolution to Redomicile from Australia to the United States

Business Wire

a year ago

Cenntro Electric Group Encourages All Shareholders to Vote in Favor of Proposed Scheme Resolution to Redomicile from Australia to the United States

PodcastOne (NASDAQ: PODC) Continues to Expand Its Award Winning Slate With the Launch of Varnamtown Podcast

GlobeNewswire

a year ago

PodcastOne (NASDAQ: PODC) Continues to Expand Its Award Winning Slate With the Launch of Varnamtown Podcast

Insider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...

GuruFocus.com

a year ago

Insider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...

Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

GlobeNewswire

a year ago

Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

Nuvectis Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Nuvectis Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Cenntro Regains Compliance with Nasdaq Minimum Bid Price Rule

Business Wire

a year ago

Cenntro Regains Compliance with Nasdaq Minimum Bid Price Rule

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

InvestorPlace

a year ago

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

Cenntro Electric Group’s LS400 Approved for California’s Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project

Business Wire

a year ago

Cenntro Electric Group’s LS400 Approved for California’s Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project

Humble Imports, Inc., the Wholly Owned Subsidiary of ECD Automotive Design, Reports 68% Increase in Revenue, Positive Net Income, for Third Quarter of 2023

GlobeNewswire

a year ago

Humble Imports, Inc., the Wholly Owned Subsidiary of ECD Automotive Design, Reports 68% Increase in Revenue, Positive Net Income, for Third Quarter of 2023

Loop Media, Inc. (PNK:LPTV) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Loop Media, Inc. (PNK:LPTV) Q4 2023 Earnings Call Transcript

Loop Media Reports Full Year 2023 and Fourth Quarter Fiscal Financial Results

Business Wire

a year ago

Loop Media Reports Full Year 2023 and Fourth Quarter Fiscal Financial Results

Carbon Revolution Provides Business Update

GlobeNewswire

a year ago

Carbon Revolution Provides Business Update

BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

a year ago

BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

IMUNON Appoints Dr. Sebastien Hazard as Chief Medical Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

IMUNON Appoints Dr. Sebastien Hazard as Chief Medical Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sonder Holdings Inc. Appoints Tom Buoy as Executive Vice President and Chief Commercial Officer

Business Wire

a year ago

Sonder Holdings Inc. Appoints Tom Buoy as Executive Vice President and Chief Commercial Officer

BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs

GlobeNewswire

a year ago

BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs

LightPath Technologies Schedules Annual Meeting of Stockholders

ACCESSWIRE

a year ago

LightPath Technologies Schedules Annual Meeting of Stockholders

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia

GlobeNewswire

a year ago

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia

10 Best Debt Free Penny Stocks To Buy Now

Insider Monkey

a year ago

10 Best Debt Free Penny Stocks To Buy Now

Intellinetics to Participate at the Ohio Association of County Boards 40th Annual Convention

Business Wire

a year ago

Intellinetics to Participate at the Ohio Association of County Boards 40th Annual Convention

Maison Solutions Closes Private Placement

ACCESSWIRE

a year ago

Maison Solutions Closes Private Placement

Imunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Imunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript

Capital Allocation Trends At Computer Programs and Systems (NASDAQ:CPSI) Aren't Ideal

Simply Wall St.

a year ago

Capital Allocation Trends At Computer Programs and Systems (NASDAQ:CPSI) Aren't Ideal

Zacks Small Cap Research

a year ago

IMNN: Promising Interim PFS and OS Data for IMNN-001 in OVATION 2 Trial…

Sonder Holdings Inc. Announces Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

Sonder Holdings Inc. Announces Third Quarter 2023 Financial Results

IMUNON’s VP of R&D to Present at the Vaccines Summit-2023

GlobeNewswire

a year ago

IMUNON’s VP of R&D to Present at the Vaccines Summit-2023

IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update

GlobeNewswire

a year ago

IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

GlobeNewswire

a year ago

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

LightPath Technologies Postpones Annual Meeting of Stockholders

ACCESSWIRE

a year ago

LightPath Technologies Postpones Annual Meeting of Stockholders

Share on Social Networks: